Key highlights
- Bob Waitt appointed Chief Commercial Officer at Momentive, effective April 27, 2026.
- He joins from Elkem ASA Silicones Division after 12 years in global commercial leadership.
- Previously President & CEO of Albright Technologies, a silicone molding and medical device firm.
- Charged with commercial strategy to drive revenue growth and expand market presence for silicone and specialty solutions.
Appointment
Bob Waitt was appointed Chief Commercial Officer of Momentive Performance Materials, effective April 27, 2026.
Mandate
He will lead the company’s commercial strategy, responsible for driving revenue growth, expanding market presence and aligning customer needs with regional and organizational priorities.
Experience
Waitt joins from Elkem ASA Silicones Division after 12 years in global commercial leadership roles where he unified sales teams, improved commercial operations and built high-performing teams focused on financial outcomes.
Prior roles and education
Earlier he was President & CEO of Albright Technologies, overseeing silicone molding and medical device manufacturing operations; he holds a Bachelor of Science in Electrical Engineering from Boston University.
